Sanofi to boost Canadian presence with Canderm buy; GSK wins conditional EU nod for Votrient;

@FiercePharma: Bloomberg: McNeil president ordered 'phantom recall.' Report | Follow @FiercePharma

> Sanofi-Aventis said it is buying the assets of Montreal's privately held skin care firm Canderm Pharma through its Canadian subsidiary. ReleaseReport

> GlaxoSmithKline's new kidney cancer drug Votrient won conditional approval from the European Commission, paving the way for its rollout across the European Union. Report

> When analyzing the value of a drug, more than half of patients look to cost, but only 4 percent of biopharma executives do, a new survey shows. Report

> Sigma Pharmaceuticals, the target of a takeover bid from Aspen Pharmacare Holdings, named a former chief financial officer to its top job after posting a record loss. Report

> Cipla, the Indian drugmaker that built a $1 billion business making generic HIV treatments, aims to sell copies of Roche's and Amgen's best- selling biotechnology medicines with a partner in China. Report

> Teva Pharmaceutical Industries launched its $2.5 billion bond offering to raise money to help finance its acquisition of German generics maker Ratiopharm. Report

> Medco Health Solutions has seen a benefit to its selling season for next year from a fight between rival pharmacy benefit manager CVS Caremark and drugstore chain Walgreen. Report

Biotech News

 @FierceBiotech: Genmab CEO Lisa Drakeman (photo) bows out of the weakened biotech. Report | Follow @FierceBiotech

 @JohnCFierce: On the ropes after TNFerade fiasco, GenVec considers its limited options. Report | Follow @JohnCFierce

> Amylin's Bydureon fails to impress in head-to-head trial. Report

> Cipla targets $19B biosimilar market with string of new deals. News

> GTC's CEO is out as company axes 50 staffers. Report

> Curis shares plunge after lead drug flunks cancer trial. Article

> On a roll, Neurocrine nails $575M licensing deal with Abbott. Story

Medical Device News

> Abbott Vascular cuts 120 jobs. Report

> FDA recalls fake surgical mesh. Story

> Dx company Veracyte lands $28M series B. Article

> Appeals court gives TriMed a win in patent dispute. Item

> Predictive Biosciences gains $25M for cancer Dx. Item

Drug Delivery News

> Savara wins $1.9M award for dry-powder tech. News

> New hybrid nanoparticles offer precise cell targeting. Report

> T-DM1 success inspires a wave of antibody-drug combos. Story

> "Smart" nanocapsules created for protein drug delivery. Report 

> Injectable bone fluid can deliver stem cells, protein drugs. Article

And Finally... Fido can get his flu shot now, thanks to a newly approved shot to prevent H3N8 influenza from Intervet/Schering-Plough Animal Health. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.